Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maqui berry extract is a botanical product derived from the fruit of *Aristotelia chilensis*, a shrub native to the temperate forests of Chile and Argentina. The extract is characterized by a high concentration of anthocyanins, particularly delphinidins and cyanidin derivatives, which contribute to its potent antioxidant, anti-inflammatory, and antiplatelet properties. A standardized form known as Delphinol is commonly used in research and dietary supplements. The extract acts by modulating multiple platelet activation pathways—including thromboxane, thrombin, and ADP receptors—and reducing oxidative stress markers. It is being investigated for its potential therapeutic benefits in cardiovascular disease, various inflammatory skin conditions (such as dermatitis, psoriasis, and eczema), and pain management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on maqui berry extract.